The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Open accessAbstract
DNA methylation in promoters is well known to silence genes and is the presumed therapeutic target of methylation inhibitors. Gene body methylation is positively correlated with expression, yet its function is unknown. We show that 5-aza-2'-deoxycytidine treatment not only reactivates genes but decreases the overexpression of genes, many of which are involved in metabolic processes regulated by c-MYC. Downregulation is caused by DNA demethylation of the gene bodies and restoration of high levels of expression requires remethylation by DNMT3B. Gene body methylation may, therefore, be an unexpected therapeutic target for DNA methylation inhibitors, resulting in the normalization of gene overexpression induced during carcinogenesis. Our results provide direct evidence for a causal relationship between gene body methylation and transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased CGI gene body methylation positively correlates with transcriptional activation [6, 25, 55]”
From Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression (2024) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is well-known that promoter CGI hypermethylation represses transcription [43, 45], whereas hypermethylation at gene body CGIs activates gene expression [6, 55].”
From Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression (2024) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and that the location of these CGIs determines the direction of this regulation [6, 43, 45, 55]”
From Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression (2024) · cites this paper as [55]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Another study demonstrated a positive correlation between gene expression and gene body methylation.55”
From Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential (2023) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“it is widely accepted that the level of methylation in the regions known as CGI regulates gene expression”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Self-citationConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,888
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Self-citationCellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 999
Li, Z., Tan, H., Yu, H., Deng, Z., Zhou, X., & Wang, M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29463 · Cited by 26
Li, S. N., Li, W., Wu, R., Yin, R., Sargsyan, D., Raskin, I., & Kong, A. T. (2019) · The AAPS Journal · doi:10.1208/s12248-019-0393-z · Cited by 26
Global RNA Expression and DNA Methylation Patterns in Primary Anaplastic Thyroid Cancer
Ravi, N., Yang, M., Mylona, N., Wennerberg, J., & Paulsson, K. (2020) · Cancers · doi:10.3390/cancers12030680 · Cited by 27
Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease
González-Latapí, P., Bustos, B. I., Dong, S., Lubbe, S. J., Simuni, T., & Krainc, D. (2024) · Annals of Neurology · doi:10.1002/ana.26923 · Cited by 26
Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms
Yu, X., Jia, L., Tang, Q., Zhou, Q., Wang, G., & Wang, S. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01961-6 · Cited by 25
Elsemman, I. E., Mardinoğlu, A., Shoaie, S., Soliman, T. H. A., & Nielsen, J. (2016) · Molecular BioSystems · doi:10.1039/c5mb00827a · Cited by 26
Stomper, J., Ihorst, G., Suciu, S., Sander, P. N., Becker, H., Wijermans, P., Plass, C., Weichenhan, D., Bissé, E., Claus, R., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.187278 · Cited by 25
Goyal, D., & Goyal, R. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01502 · Cited by 25
Unravelling the Epigenome of Myelodysplastic Syndrome: Diagnosis, Prognosis, and Response to Therapy
Bond, D. R., Lee, H. J., & Enjeti, A. K. (2020) · Cancers · doi:10.3390/cancers12113128 · Cited by 26
Pischedda, S., Calle, I. R., Gómez‐Carballa, A., Cebey‐López, M., Barral‐Arca, R., Rial, J. G., Pardo‐Seco, J., Currás-Tuala, M. J., Viz-Lasheras, S., Bello, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.875691 · Cited by 24
Yu, H., Wang, X., Bai, L., Tang, G., Carter, K. T., Cui, J., Huang, P., Li, L., Ding, Y., Cai, M., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac183 · Cited by 25
The Role of DNA Methylation and DNA Methyltransferases in Cancer
Weisenberger, D. J., Lakshminarasimhan, R., & Liang, G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11454-0_13 · Cited by 27
Self-citationNojima, M., Matsui, T., Tamori, A., Kubo, S., Shirabe, K., Kimura, K., Shimada, M., Utsunomiya, T., Kondo, Y., Iio, E., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0514-6 · Cited by 24
Role of DNA Methylation in Genome Stability
Zhou, D., & Robertson, K. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803309-8.00024-0 · Cited by 25
Moody, L., Chen, H., & Pan, Y. (2017) · Epigenomics · doi:10.2217/epi-2017-0066 · Cited by 24
Robust prediction of gene regulation in colorectal cancer tissues from DNA methylation profiles
Klett, H., Balavarca, Y., Tóth, R., Gigic, B., Habermann, N., Scherer, D., Schrotz‐King, P., Ulrich, A. B., Schirmacher, P., Herpel, E., et al. (2018) · Epigenetics · doi:10.1080/15592294.2018.1460034 · Cited by 24
Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer
Li, J., Su, X., Dai, L., Chen, N., Fang, C., Dong, Z., Fu, J., Yu, Y., Wang, W., Zhang, H., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz199 · Cited by 24
Wang, Q., Zhou, Y.-C., Ge, Y.-J. Z., Qin, G., Yin, T., Zhao, D., Tan, C., & Yao, S. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i22.7686 · Cited by 24
Varol, N., Keleş, İ., Yıldız, H., Karaosmanoğlu, C., Karalar, M., Zengın, K., Sarıcı, H., & Tokyol, Ç. (2023) · Gene · doi:10.1016/j.gene.2023.147352 · Cited by 24
O’Doherty, A. M., McGettigan, P., Irwin, R. E., Magee, D. A., Gagné, D., Fournier, É., Al-Naib, A., Sirard, M., Walsh, C. P., Robert, C., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4818-3 · Cited by 25
Is maternal microbial metabolism an early-life determinant of health?
Romano, K. A., & Rey, F. E. (2018) · Lab Animal · doi:10.1038/s41684-018-0129-1 · Cited by 25
To live or let die? Epigenetic adaptations to climate change—a review
Zetzsche, J., & Fallet, M. (2024) · Current Zoology · doi:10.1093/eep/dvae009 · Cited by 27
Comparison of current methods for genome-wide DNA methylation profiling
de Abreu, A. R., Ibrahim, J., Lemonidis, V., Mateiu, L. M., Camp, G. V., & de Beeck, K. O. (2025) · Epigenetics & Chromatin · doi:10.1186/s13072-025-00616-3 · Cited by 23
Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect?
Samadani, A. A., Norollahi, S. E., Mansour‐Ghanaei, F., Rashidy‐Pour, A., Joukar, F., & Bandegi, A. R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.094 · Cited by 23
Sex-specific DNA methylation differences in people exposed to polybrominated biphenyl
Curtis, S. W., Gerkowicz, S. A., Cobb, D. O., Kilaru, V., Terrell, M. L., Marder, M. E., Barr, D. B., Marsit, C. J., Marcus, M., Conneely, K. N., et al. (2020) · Epigenomics · doi:10.2217/epi-2019-0179 · Cited by 23
A Deep Learning–Based Framework for Supporting Clinical Diagnosis of Glioblastoma Subtypes
Munquad, S., Si, T., Mallik, S., Das, A. B., & Zhao, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.855420 · Cited by 23
Pongor, L. S., Tlemsani, C., Elloumi, F., Arakawa, Y., Jo, U., Gross, J., Mosavarpour, S., Varma, S., Kollipara, R. K., Roper, N., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105338 · Cited by 24
Role of epigenetics in OSCC: an understanding above genetics
Vatsa, P. P., Jindal, Y., Bhadwalkar, J., Chamoli, A., Upadhyay, V., & Mandoli, A. (2023) · Medical Oncology · doi:10.1007/s12032-023-01992-0 · Cited by 26
Yang, G., Yu, X., Weisenberger, D. J., Lü, T., & Liang, G. (2023) · Cancers · doi:10.3390/cancers15112934 · Cited by 25
Self-citationSETD2 Deficiency Confers Sensitivity to Dual Inhibition of DNA Methylation and PARP in Kidney Cancer
Zhou, X., Sekino, Y., Li, H., Fu, G., Zhi, Y., Zhao, S., Gujar, H., Zu, X., Weisenberger, D. J., Gill, I. S., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0401 · Cited by 25
Self-citationShi, J., Fu, L. N., Ang, Q., Wang, G., Zhu, J., & Wang, W. (2015) · Oncotarget · doi:10.18632/oncotarget.6226 · Cited by 23
Role of epigenome in tumorigenesis and drug resistance
Hu, Q., & Baeg, G. H. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.07.022 · Cited by 23
Madrid, A., Chopra, P., & Alisch, R. S. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00039 · Cited by 24
The molecular hallmarks of epigenetic effects mediated by antiepileptic drugs
Navarrete-Modesto, V., Orozco-Suárez, S. A., Feria-Romero, I. A., & Rocha, L. (2018) · Epilepsy Research · doi:10.1016/j.eplepsyres.2018.11.006 · Cited by 23
Zhang, W., Zhang, S., Xu, Y., Ma, Y., Zhang, D., Li, X., & Zhao, S. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00220 · Cited by 23
DNA methylation in hematopoietic development and disease
Gore, A. V., & Weinstein, B. M. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.04.013 · Cited by 26
SnoRNAs: The promising targets for anti-tumor therapy
Hu, X., Cui, W., Liu, M., Zhang, F., Zhao, Y., Zhang, M., Yin, Y., Li, Y., Che, Y., Zhu, X., et al. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101064 · Cited by 24
Clukay, C. J., Hughes, D. A., Rodney, N. C., Kertes, D. A., & Mulligan, C. J. (2017) · American Journal of Physical Anthropology · doi:10.1002/ajpa.23341 · Cited by 21
(Epi)genetic regulation of CRTC1 in human eating behaviour and fat distribution
Rohde, K., Keller, M., Poulsen, L. L. C., Rønningen, T., Stümvoll, M., Tönjes, A., Kovacs, P. L., Horstmann, A., Villringer, A., Blüher, M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.05.050 · Cited by 22
Dong, L., Zhang, Z., Xu, J., Wang, F., Ma, Y., Li, F., Shen, C., Liu, Z., Zhang, J., Liu, C., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12527 · Cited by 22
RetractedDNA-methylation dynamics across short-term, exposure-containing CBT in patients with panic disorder
Moser, S., Martins, J., Czamara, D., Lange, J. F., Müller‐Myhsok, B., & Erhardt, A. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01802-7 · Cited by 24
Bai, J., Zheng, A., Ha, Y., Xu, X., Yu, Y., Lu, Y., Zheng, S., Shen, Z., Luo, B., & Jie, W. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.988777 · Cited by 22
Ajuyah, P., Mayoh, C., Lau, L. M. S., Barahona, P., Wong, M., Chambers, H., Valdés‐Mora, F., Senapati, A., Gifford, A. J., D’Arcy, C. E., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-30395-4 · Cited by 22
Gómez-Campo, K., Sánchez, R., Martinez-Rugerio, M. I., Yang, X., Maher, T., Osborne, C. C., Enríquez, S., Baums, I. B., Mackenzie, S. A., & Iglesias‐Prieto, R. (2023) · Molecular Ecology · doi:10.1111/mec.17246 · Cited by 22
Self-citationOmics-based molecular classifications empowering in precision oncology
Zhou, Z., Lin, T., Chen, S., Zhang, G., Xu, Y., Zou, H., Zhou, A., Zhang, Y., Weng, S., Han, X., et al. (2024) · Cellular Oncology · doi:10.1007/s13402-023-00912-8 · Cited by 24
Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies
Akkad, J., Bochum, S., & Martens, U. M. (2015) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-015-1276-0 · Cited by 22
Wang, Y., Jadhav, R. R., Liu, J. K., Wilson, D., Chen, Y., Thompson, I. M., Troyer, D. A., Hernández, J., Shi, H., Leach, R. J., et al. (2016) · Scientific Reports · doi:10.1038/srep22051 · Cited by 22
Liu, S., Yin, P., Xu, J., Dotts, A. J., Kujawa, S. A., Coon, J. S., Zhao, H., Shilatifard, A., Dai, Y. D., & Bulun, S. E. (2020) · Endocrinology · doi:10.1210/endocr/bqaa143 · Cited by 22
DNA methylation at enhancer regions Novel avenues for epigenetic biomarker development
Helgason, C. D. (2015) · Frontiers in bioscience · doi:10.2741/4399 · Cited by 24
Ayele, F. T., Biedrzycki, R. J., Habtewold, T. D., Wijesiriwardhana, P., Burt, A., Marsit, C. J., Ouidir, M., & Wapner, R. J. (2025) · Nature Communications · doi:10.1038/s41467-025-58128-3 · Cited by 21
Kim, W., Fry, R. C., & Tilley, S. K. (2019) · Europe PMC (PubMed Central) · doi:10.17615/74p3-qm54 · Cited by 21
Fiedler, D., Hirsch, D. D., Hajj, N. E., Yang, H. H., Hu, Y., Sticht, C., Nanda, I., Belle, S., Rueschoff, J., Lee, M. P., et al. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22787 · Cited by 21
Abdulrahim, J. W., Kwee, L. C., Grass, E. A., Siegler, I. C., Williams, R. B., Karra, R., Kraus, W. E., Gregory, S. G., & Shah, S. H. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013228 · Cited by 20
Hu, Q., Zhou, S., Hu, X., Zhang, H., Huang, S., & Wang, Y. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14814 · Cited by 22
Pang, F.-M., Yan, H., Mo, J.-L., Li, D., Chen, Y., Zhang, L., Liu, Z., Zhou, H., Wu, J., & Li, X. (2020) · Future Oncology · doi:10.2217/fon-2019-0764 · Cited by 21
Aberrantly Methylated and Expressed Genes as Prognostic Epigenetic Biomarkers for Colon Cancer
Wu, Y., Wan, X., Jia, G., Xu, Z., Tao, Y., Song, Z., & Du, T. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5591 · Cited by 21
Gujar, H., Mehta, A., Li, H., Tsai, Y., Qiu, X., Weisenberger, D. J., Jasiulionis, M. G., In, G. K., & Liang, G. (2021) · Genome Medicine · doi:10.1186/s13073-021-00946-3 · Cited by 21
Self-citationTranscriptional and Epigenetic Regulation of Context-Dependent Plasticity in T-Helper Lineages
Friedman, M. J., Lee, H., Lee, J., & Oh, S. (2023) · Immune Network · doi:10.4110/in.2023.23.e5 · Cited by 22
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
He, Z., Song, B., Zhu, M., & Liu, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-31226-2 · Cited by 21
DNA Methylation and Sex Allocation in the Parasitoid Wasp Nasonia vitripennis
Cook, N., Pannebakker, B. A., Tauber, E., & Shuker, D. M. (2015) · The American Naturalist · doi:10.1086/682950 · Cited by 22
Cincinelli, R., Zwick, V., Musso, L., Zuco, V., Cesare, M. D., Zunino, F., Simões‐Pires, C. A., Nurisso, A., Giannini, G., Cuendet, M., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.001 · Cited by 21
O’Doherty, A., Fenza, M. D., & Kölle, S. (2016) · Scientific Reports · doi:10.1038/srep24583 · Cited by 21
Glowacka, W. K., Jain, H., Okura, M. K., Maimaitiming, A., Mamatjan, Y., Nejad, R., Farooq, H., Taylor, M. D., Aldape, K., & Kongkham, P. N. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1821-3 · Cited by 21
Andraos, S., de Seymour, J. V., O'Sullivan, J. M., & Kussmann, M. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800034 · Cited by 20
Sun, W., Chatterjee, B., Shern, J. F., Patidar, R., Song, Y., Wang, Y., Walker, R. L., Pawel, B., Linardic, C. M., Houghton, P. J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32006 · Cited by 21
Mishra, N. K., Niu, M., Southekal, S., Bajpai, P., Elkholy, A., Manne, U., & Guda, C. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.522125 · Cited by 21
Virakul, S., Somparn, P., Pisitkun, T., van der Spek, P. J., Dalm, V. A. S. H., Paridaens, D. A., van Hagen, P. M., Hirankarn, N., Palaga, T., & Dik, W. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.619989 · Cited by 21
Zimmer‐Bensch, G. (2018) · Brain Research · doi:10.1016/j.brainres.2018.09.001 · Cited by 22
Hemimethylation: DNA's lasting odd couple
Sharif, J., & Koseki, H. (2018) · Science · doi:10.1126/science.aat0789 · Cited by 19
Rondelet, G., & Wouters, J. (2017) · Biochimie · doi:10.1016/j.biochi.2017.06.003 · Cited by 21
Jin, W. Y., Li, Q., Zuo, Y., Cao, Y., Zhang, L.-Q., Hou, R., & Su, W. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4276 · Cited by 20
DNA methyltransferase inhibition reduces inflammation-induced colon tumorigenesis
Maiuri, A. R., Savant, S. S., Podicheti, R., Rusch, D. B., & O’Hagan, H. M. (2019) · Epigenetics · doi:10.1080/15592294.2019.1634986 · Cited by 21
ENPP2 Methylation in Health and Cancer
Παναγοπούλου, Μ., Fanidis, D., Aidinis, V., & Chatzaki, Ε. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111958 · Cited by 20
Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
Zhou, S., Wang, X., Ding, J., Yang, H., & Xie, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.757184 · Cited by 21
RGS10 suppression by DNA methylation is associated with low survival rates in colorectal carcinoma
Caldiran, F. Y., & Çaçan, E. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154007 · Cited by 20
Epigenomics: a new tool for the generation of climate resilient grapevines
Tan, J. W., & Lopez, C. M. R. (2023) · Frontiers in Horticulture · doi:10.3389/fhort.2023.1116866 · Cited by 23
Wang, N., Hu, Y., & Wang, Z. (2023) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1815 · Cited by 26
Genome-wide association study identifies novel type II diabetes risk loci in Jordan subpopulations
Dajani, R. B., Li, J., Wei, Z., March, M., Xia, Q., Khader, Y. S., Hakooz, N., Fatahallah, R., El-Khateeb, M. S., Arafat, A., et al. (2017) · PeerJ · doi:10.7717/peerj.3618 · Cited by 22
Bowden, S. A., Stockwell, P. A., Rodger, E. J., Parry, M. F., Eccles, M. R., Stayner, C., & Chatterjee, A. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00348 · Cited by 20
Epigenetic Mechanisms in Canine Cancer
Xavier, P. L. P., Müller, S., & Fukumasu, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.591843 · Cited by 20
Sibley, L. A., Broda, N., Gross, W. R., Menezes, A. F., Embry, R. B., Swaroop, V. T., Chambers, H. G., Schipma, M. J., Lieber, R. L., & Domenighetti, A. A. (2021) · The FASEB Journal · doi:10.1096/fj.202100649r · Cited by 20
Tian, Y., Yang, X., Du, J., Zeng, W., Wu, W., Di, J., Huang, X., & Tian, K. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.735827 · Cited by 20
Self-citationKong, W., Chen, Y., Zhao, Z., Zhang, L., Lin, X., Luο, X., Wang, S., Song, Z., Lin, X., Lai, G., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16277 · Cited by 19
Cortes, L. R., Cisternas, C. D., Cabahug, I. N. K. V., Mason, D., Ramlall, E. K., Castillo‐Ruiz, A., & Forger, N. G. (2021) · Neuroendocrinology · doi:10.1159/000519671 · Cited by 23
Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation
An, J., & Ko, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021727 · Cited by 21
DNA methylation dynamics: identification and functional annotation
Liu, H., Li, S., Wang, X., Zhu, J., Wei, Y., Wang, Y., Wen, Y., Wang, L., Huang, Y., Zhang, B., et al. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw029 · Cited by 19
Pre-implantation alcohol exposure and developmental programming of FASD: an epigenetic perspective
Legault, L., Bertrand-Lehouillier, V., & McGraw, S. (2017) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0141 · Cited by 19
Histone H3.3K27M Mobilizes Multiple Cancer/Testis (CT) Antigens in Pediatric Glioma
Deng, H., Zeng, J., Zhang, T., Gong, L., Zhang, H., Cheung, E. C. W., Jones, C., & Li, G. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0460 · Cited by 19
Epigenetic influences on genetically triggered thoracic aortic aneurysm
Portelli, S. S., Robertson, E., Malecki, C., Liddy, K. A., Hambly, B. D., & Jeremy, R. (2018) · Biophysical Reviews · doi:10.1007/s12551-018-0460-1 · Cited by 19
Aberrant DNA methylation defines isoform usage in cancer, with functional implications
Chen, Y.-C., & Elnitski, L. L. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007095 · Cited by 19
Russell‐Hallinan, A., Watson, C. J., O’Dwyer, D., Grieve, D., & O’Neill, K. M. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07019-4 · Cited by 18
Shimizu, R., Muto, T., Aoyama, K., Choi, K., Takeuchi, M., Koide, S., Hasegawa, N., Isshiki, Y., Togasaki, E., Kawajiri‐Manako, C., et al. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.09.018 · Cited by 19
Kulecka, M., O’Sullivan, J., Fitzgerald, R. S., Velikonja, A., Huseyin, C. E., Mendieta, E. J. L., Ruiz‐Limón, P., Eckenberger, J., Vidal-Marín, M., Truppel, B.-A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62533-z · Cited by 20
Liu, S., Yang, Z., Li, G., Li, C., Luo, Y., Gong, Q., Xin, W., Li, T., Zhang, Z., Xing, B., et al. (2019) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2018.07.008 · Cited by 18
Altıntaş, A., Liu, J., Fabre, O., Chuang, T., Wang, Y., Sakurai, R., Chehabi, G. N., Barrès, R., & Rehan, V. K. (2021) · The FASEB Journal · doi:10.1096/fj.202100215r · Cited by 19
Lin, M., Zhong, H.-Y., Yim, R., Chen, Q., Du, H., He, H., Lin, K., Zhao, P., Gao, R., Gao, F., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10155-9 · Cited by 19
The Interplay between Dysregulated Metabolism and Epigenetics in Cancer
Bassal, M. A. (2023) · Biomolecules · doi:10.3390/biom13060944 · Cited by 19
Fujiyoshi, S., Honda, S., Ara, M., Kondo, T., Kobayashi, N., & Taketomi, A. (2023) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.1391 · Cited by 18
Alterations in DNA methylation patterns and gene expression in spermatozoa of subfertile males
Laqqan, M. M., & Hammadeh, M. E. (2017) · Andrologia · doi:10.1111/and.12934 · Cited by 19
Ye, X., Mo, M., Xu, S., Yang, Q., Wu, M., Zhang, J., Chen, B., Li, J., Zhong, Y., Huang, Q., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4921-5 · Cited by 18
Metadata
- Authors
- Yang, X., Han, H., De Carvalho, D. D., Lay, F. D., Jones, P. A., & Liang, G.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Jones, Peter A.
- Liang, Gangning
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 26
- Issue
- 4
- Pages
- 577-590
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC4224113
- OpenAlex
- W2055986128
- Cited by
- 1,199
- References
- 62
- Citations by year
- 2026: 61 · 2025: 77 · 2024: 104 · 2023: 109 · 2022: 105 · 2021: 120 · 2020: 120 · 2019: 134 · 2018: 128 · 2017: 97 · 2016: 79 · 2015: 55 · 2014: 8
- FWCI
- 32.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Princess Margaret Cancer Foundation
- National Institutes of Health
- National Cancer Institute (R01CA170550, R01CA124518, R01CA082422, P30CA014089, R37CA082422)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- gene body methylation, DNA methylation, decitabine, DNA demethylation, DNMT3B, c-Myc, gene overexpression, transcriptional regulation, DNA methylation inhibitors, cancer therapy, carcinogenesis, metabolic genes
- MeSH terms
- Cell Division, Colonic Neoplasms, Humans, Promoter Regions, Genetic, Gene Expression, DNA Methylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review